Herceptin & Roche in India: The battle for life-saving treatment (A)
This case series looks at the actions taken by NGOs, local campaigners and the Indian government, against Roche over its patent for a breast cancer drug “Trastuzumab”, otherwise known as “Herceptin”, Herceptin was an expensive but highly effective treatment for some types of breast cancer and campaigners were vocal in arguing that in emerging markets, such as India, it was beyond the means of the majority of the population. Case A covers the campaign and actions until December 2012. Although Roche reduced the price of Herceptin and entered into an agreement with a local company to produce a generic version at a lower price, the campaign for greater access continued.
This case series looks to understand how NGOs and local campaigners can affect a company’s ability to market its products or operate in emerging markets.
Roche, Healthcare, Pharmaceuticals
2012
Cranfield University
Wharley End Beds MK43 0JR, UK
Tel +44 (0)1234 750903
Email [email protected]
Harvard Business School Publishing
60 Harvard Way, Boston MA 02163, USA
Tel (800) 545-7685 Tel (617)-783-7600
Fax (617) 783-7666
Email [email protected]
NUCB Business School
1-3-1 Nishiki Naka
Nagoya Aichi, Japan 460-0003
Tel +81 52 20 38 111
Email [email protected]
IMD retains all proprietary interests in its case studies and notes. Without prior written permission, IMD cases and notes may not be reproduced, used, translated, included in books or other publications, distributed in any form or by any means, stored in a database or in other retrieval systems. For additional copyright information related to case studies, please contact Case Services.
Research Information & Knowledge Hub for additional information on IMD publications
This study offers novel insights into how team structure and flexibility affect pivoting. It details how founding team coordination practices shape individual and collective sensemaking of feedback and efforts to improve a venture idea. Following ...
Explore an IMD white paper with Microsoft and EqualVoice, launched at Davos, addressing GenAI bias risks and offering survey insights and recommendations.
Last year saw a nearly 60% surge in phishing attacks. While systemic defenses against such threats offer valuable protection, they are not enough. Enhance your resistance to phishing by taking this short quiz. Last year saw a nearly 60% surge in p...
Honda and Nissan's $58bn merger aims to compete with China's EV dominance, but risks include cultural clashes, overlapping markets, and uncertain innovation outcomes.
Explore top books, websites, and podcasts recommended by IMD expert Jim Pulcrano for anyone venturing into or exploring venture capital, from entrepreneurs to investors.
David Michels, CFO at Kinder Morgan, a US energy infrastructure company, explores how rapid AI and data center growth have quickly reshaped energy demand
Corporate DE&I is not simply a question of fairness. Implemented successfully, it pays off for both the company and society in general. Here’s how it’s done. Corporate DE&I is not simply a question of fairness. Implemented successfully, it pays of...
Corporate DE&I is not simply a question of fairness. Implemented successfully, it pays off for both the company and society in general. Here's how it's done.
At Davos' SDG Tent, panelists urged a shift from financial metrics to valuing natural, social, and human capital for sustainable prosperity. Julia Binder
Explore how perceptions of leadership evolved. Anand Narasimhan delves into archetypes, offering insights to shape your responsible leadership approach.
in Journal of Business Venturing March 2025, vol. 40, no. 2, 106472, https://doi.org/10.1016/j.jbusvent.2024.106472
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
in I by IMD
Research Information & Knowledge Hub for additional information on IMD publications
in I by IMD
Research Information & Knowledge Hub for additional information on IMD publications
in I by IMD Brain Circuits 22 January 2025
Research Information & Knowledge Hub for additional information on IMD publications
in I by IMD
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications